糖尿病神经病变是全膝关节置换术后骨科不良结局的强危险因素
这项回顾性队列研究利用2005至2022年全球临床研究网络数据,纳入318,851例全膝关节置换患者,按糖尿病及糖尿病周围神经病变状态分层。经倾向性评分匹配后,与无神经病变的糖尿病患者相比,糖尿病周围神经病变患者术后2年内关节感染、假体周围骨折和翻修手术风险更高;与无糖尿病患者相比,其2年骨科并发症风险也显著更高。
要点
- 糖尿病周围神经病变患者全膝关节置换术后2年内关节感染风险较无神经病变糖尿病患者升高(RR 1.69)。
- 糖尿病周围神经病变患者假体周围骨折风险(RR 1.64)和翻修手术风险(RR 1.49)均较无神经病变糖尿病患者升高。
- 与无糖尿病患者相比,糖尿病周围神经病变患者2年骨科并发症风险显著更高。
核心结论
- 与无糖尿病患者及无神经病变的糖尿病患者相比,糖尿病神经病变与全膝关节置换术后内科和外科并发症发生几率更高相关。
- 糖尿病神经病变与关节感染、假体周围骨折和翻修手术的更高发生几率相关。
- 骨科医生应意识到糖尿病神经病变带来的额外手术风险,这一风险独立于糖尿病整体影响之外。
研究设计与样本
- 本研究为回顾性队列研究,使用全球临床研究网络2005至2022年收集的数据。
- 通过国际疾病分类第10版和现行 procedural 术语代码识别接受全膝关节置换术的患者。
- 按糖尿病状态和糖尿病神经病变存在与否对患者进行分层。
- 术后2年内评估骨科并发症,90天内评估内科和住院并发症。
- 采用1:1倾向性评分匹配控制基线协变量,包括年龄、性别、体重指数、Charlson合并症指数及适用时的糖化血红蛋白。
主要发现
- 研究共纳入318,851例接受全膝关节置换术的患者:无糖尿病患者227,597例(71.4%),有糖尿病但无糖尿病神经病变患者68,694例(21.5%),糖尿病神经病变患者22,560例(7.1%)。
- 与无神经病变的糖尿病患者相比,在按糖化血红蛋白水平匹配后,糖尿病神经病变患者术后2年内关节感染风险更高(RR 1.69,P < 0.001)。
- 与无神经病变的糖尿病患者相比,糖尿病神经病变患者假体周围骨折风险更高(RR 1.64,P < 0.001)。
- 与无神经病变的糖尿病患者相比,糖尿病神经病变患者翻修手术风险更高(RR 1.49,P < 0.001)。
- 与无糖尿病患者相比,糖尿病神经病变患者2年骨科并发症风险显著更高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to investigate the impact of diabetic peripheral neuropathy (DPN) on total knee arthroplasty (TKA) outcomes when compared with both nondiabetic and diabetic patients who did not have neuropathy (DM). METHODS: This retrospective cohort study utilized a global clinical research network, comprising data collected between 2005 and 2022. Patients undergoing TKA were identified using international classification of diseases, 10th revision and Current Procedural Terminology codes. Patients were stratified based on diabetes status and the presence of diabetic neuropathy. Orthopaedic complications were assessed over a 2-year period postoperatively, while medical and hospital complications were evaluated within 90 days. Propensity score matching (1:1) was performed to control for baseline covariates, including age, sex, body mass index, Charlson Comorbidity Index, and hemoglobin A1c where applicable. Postmatching logistic regression was used to calculate risk ratios (RRs) with 95% confidence intervals. Statistical analyses were conducted with significance set at P < 0.05. RESULTS: This study included 318,851 patients who underwent TKA: 227,597 (71.4%) patients who did not have diabetes, 68,694 (21.5%) patients who had diabetes, but did not have diabetic neuropathy, and 22,560 (7.1%) patients who had diabetic neuropathy. When compared to patients who had DM, after matching for hemoglobin A1c levels, patients who had DPN had a higher risk of postoperative joint infection (RR 1.69, P < 0.001), periprosthetic fracture (RR 1.64, P < 0.001), and revision surgery (RR 1.49, P < 0.001) within two years of surgery. Compared to nondiabetic patients, those who had DPN again had significantly higher risks of 2-year orthopaedic complications. CONCLUSIONS: This study found that diabetic neuropathy, when compared with both nondiabetic and diabetic patients who did not have neuropathy, resulted in higher odds of medical and surgical complications following TKA. Specifically, diabetic neuropathy was associated with higher odds of joint infection, periprosthetic fracture, and revision surgery. Orthopaedic surgeons should be aware of the added surgical risk associated with diabetic neuropathy, outside of the impact of diabetes, overall.
引用
- Kotzur T, Barnes M, Peterson B, et al. Diabetic Neuropathy Is a Strong Risk Factor for Poor Orthopaedic Outcomes Following Total Knee Arthroplasty. J Arthroplasty. 2025. PMID: 41242350. doi:10.1016/j.arth.2025.11.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。